Assembly Biosciences (ASMB) Notes Payables (2010)
Assembly Biosciences' (ASMB) quarterly Notes Payables came in at $800000.0 in Q4 2010.
Assembly Biosciences (ASMB) Notes Payables (2010) Analysis & Trends
Assembly Biosciences' Notes Payables history runs 1 years deep, the most recent figure standing at $800000.0 for Q4 2010.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $800000.0 in Q4 2010; TTM through Dec 2010 was $800000.0, a N/A change from a year earlier, with the FY2010 full-year figure at $800000.0, changed N/A from the prior year.
- Notes Payables steadied at $800000.0 in Q4 2010 per ASMB's latest filing.
- Across five years, Notes Payables topped out at $800000.0 in Q4 2010 and bottomed at $800000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 800,000.00 |